McPherson's Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

McPherson's wird ein jährliches Gewinn- und Umsatzwachstum von 69.5% bzw. 1.7% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 76.2% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 7.4% betragen.

Wichtige Informationen

109.3%

Wachstumsrate der Gewinne

109.3%

EPS-Wachstumsrate

Personal Products Gewinnwachstum	13.1%
Wachstumsrate der Einnahmen	17.4%
Zukünftige Eigenkapitalrendite	7.9%
Analystenabdeckung	Low
Zuletzt aktualisiert	14 Jul 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

McPherson's Limited's (ASX:MCP) Share Price Not Quite Adding Up

Aug 01

McPherson's Limited's (ASX:MCP) Shares Climb 35% But Its Business Is Yet to Catch Up

Dec 18

These 4 Measures Indicate That McPherson's (ASX:MCP) Is Using Debt Reasonably Well

May 17

Did You Participate In Any Of McPherson's' (ASX:MCP) Fantastic 149% Return ?

Feb 12

Are McPherson's's (ASX:MCP) Statutory Earnings A Good Guide To Its Underlying Profitability?

Jan 25

Declining Stock and Decent Financials: Is The Market Wrong About McPherson's Limited (ASX:MCP)?

Jan 07

A Look At The Intrinsic Value Of McPherson's Limited (ASX:MCP)

Dec 20

Analysts Just Shaved Their McPherson's Limited (ASX:MCP) Forecasts Dramatically

Dec 03

Tread With Caution Around McPherson's Limited's (ASX:MCP) 5.0% Dividend Yield

Nov 22

Have Insiders Been Buying McPherson's Limited (ASX:MCP) Shares This Year?

Sep 10

Here's What McPherson's Limited's (ASX:MCP) Shareholder Ownership Structure Looks Like

Aug 19

McPherson's Limited (ASX:MCP) P/E Isn't Throwing Up Surprises

Jul 30

Is McPherson's Limited (ASX:MCP) Expensive For A Reason? A Look At Its Intrinsic Value

Jul 15

Should McPherson's Limited (ASX:MCP) Be Part Of Your Dividend Portfolio?

Jun 29

Gewinn- und Umsatzwachstumsprognosen

ASX:MCP - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (AUD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
6/30/2026	210	9	12	14	1
6/30/2025	206	8	10	12	1
6/30/2024	145	-11	10	12	N/A
12/31/2023	202	-4	18	19	N/A
9/30/2023	206	-4	11	13	N/A
6/30/2023	155	-1	5	7	N/A
3/31/2023	214	-1	5	7	N/A
12/31/2022	217	3	6	8	N/A
9/30/2022	216	1	11	13	N/A
6/30/2022	214	0	16	19	N/A
3/31/2022	211	-4	N/A	N/A	N/A
12/31/2021	208	-9	5	8	N/A
9/30/2021	204	-7	3	5	N/A
6/30/2021	201	-5	0	3	N/A
3/31/2021	210	-2	N/A	N/A	N/A
12/31/2020	218	1	16	18	N/A
9/30/2020	221	4	17	18	N/A
6/30/2020	223	6	18	19	N/A
3/31/2020	216	10	19	21	N/A
12/31/2019	210	14	20	23	N/A
9/30/2019	210	14	18	21	N/A
6/30/2019	210	14	15	20	N/A
3/31/2019	211	12	N/A	N/A	N/A
12/31/2018	211	11	-8	-4	N/A
9/30/2018	211	11	-2	1	N/A
6/30/2018	211	11	5	7	N/A
3/31/2018	207	10	N/A	14	N/A
12/31/2017	203	8	N/A	21	N/A
9/30/2017	208	4	N/A	23	N/A
6/30/2017	212	0	N/A	24	N/A
3/31/2017	235	-1	N/A	33	N/A
12/31/2016	259	-1	N/A	42	N/A
9/30/2016	286	5	N/A	34	N/A
6/30/2016	313	11	N/A	25	N/A
3/31/2016	323	10	N/A	N/A	N/A
12/31/2015	333	10	N/A	-11	N/A
9/30/2015	341	9	N/A	-2	N/A
6/30/2015	350	9	N/A	7	N/A
3/31/2015	353	11	N/A	N/A	N/A
12/31/2014	357	12	N/A	34	N/A
9/30/2014	355	-27	N/A	28	N/A
6/30/2014	353	-67	N/A	23	N/A
3/31/2014	340	-91	N/A	N/A	N/A
12/31/2013	327	-114	N/A	16	N/A
9/30/2013	313	-74	N/A	16	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: MCP wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als schnelleres Wachstum als die Sparquote angesehen wird (2.4%).

Ertrag vs. Markt: MCP wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als überdurchschnittliches Marktwachstum angesehen wird.

Hohe Wachstumserträge: MCP wird voraussichtlich in den nächsten 3 Jahren rentabel werden.

Einnahmen vs. Markt: MCPDie Einnahmen des Unternehmens (17.4% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Australian (5.4% pro Jahr).

Hohe Wachstumseinnahmen: MCPDie Einnahmen des Unternehmens (1.7% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: MCPDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (6.6%).

McPherson's Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Price target increased by 25% to AU$0.67

Price target decreased by 14% to AU$0.54

Consensus EPS estimates fall by 29%, revenue upgraded

Price target decreased by 7.9% to AU$0.78

Price target decreased by 11% to AU$0.84

Price target decreased to AU$0.84

Recent updates

Full year 2024 earnings released: AU$0.079 loss per share (vs AU$0.035 loss in FY 2023)

McPherson's Limited to Report Fiscal Year 2024 Results on Aug 29, 2024

McPherson's Limited's (ASX:MCP) Share Price Not Quite Adding Up

First half 2024 earnings released: EPS: AU$0.011 (vs AU$0.001 in 1H 2023)

Price target increased by 25% to AU$0.67

Upcoming dividend of AU$0.02 per share

New minor risk - Share price stability

McPherson's Limited Announces Executive Changes

McPherson's Limited's (ASX:MCP) Shares Climb 35% But Its Business Is Yet to Catch Up

Here's Why McPherson's (ASX:MCP) Can Manage Its Debt Responsibly

McPherson's Limited, Annual General Meeting, Nov 28, 2023

Price target decreased by 14% to AU$0.54

McPherson's (ASX:MCP) Will Pay A Smaller Dividend Than Last Year

Upcoming dividend of AU$0.01 per share at 4.0% yield

McPherson's Limited Announces Ordinary Fully Paid Dividend for the Six Months Ended June 30, 2023, Payable on September 22, 2023

Full year 2023 earnings: EPS and revenues miss analyst expectations

McPherson's Limited to Report Fiscal Year 2023 Results on Aug 24, 2023

Less than half of directors are independent

A Look At The Fair Value Of McPherson's Limited (ASX:MCP)

McPherson’s Limited Appoints Brett Charlton as Chief Executive Officer, Effective 1 August 2023

Now 22% undervalued after recent price drop

Mcpherson's Limited Announces Resignation of Grant Peck as Chief Executive Officer, Effective 31 May 2023

Consensus EPS estimates fall by 29%, revenue upgraded

These 4 Measures Indicate That McPherson's (ASX:MCP) Is Using Debt Reasonably Well

Price target decreased by 7.9% to AU$0.78

Now 24% undervalued after recent price drop

First half 2023 earnings: EPS misses analyst expectations

Price target decreased by 11% to AU$0.84

Now 23% undervalued after recent price drop

McPherson's Limited Appoints Linda Gough as Company Secretary

Price target decreased to AU$0.84

McPherson's Limited to Report First Half, 2023 Results on Feb 28, 2023

Consensus forecasts updated

McPherson's Limited Announces Resignation of Geoffrey Pearce as Director, Effective November 22, 2022

McPherson's Limited, Annual General Meeting, Nov 22, 2022

Upcoming dividend of AU$0.02 per share

Full year 2022 earnings: EPS misses analyst expectations

McPherson's Limited Declares Fully Franked Final Dividend for the Year 2022, Payable on 23 September 2022

McPherson's Limited to Report Fiscal Year 2022 Results on Aug 25, 2022

First half 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Mcpherson's Limited Announces Board Changes

McPherson's Limited Announces Changes to Its Board

McPherson's Limited to Report First Half, 2022 Results on Feb 23, 2022

Price target decreased to AU$1.19

Arrotex Pharmaceuticals Pty Limited cancelled the acquisition of McPherson's Limited (ASX:MCP) from Investors Mutual Limited, Kin Group Pty Ltd, Microequities Asset Management Pty Limited, Lennox Capital Partners and others.

Price target increased to AU$1.53

Arrotex Pharmaceuticals Pty Limited made a Non-binding Indicative Offer to acquire McPherson's Limited (ASX:MCP) from Investors Mutual Limited, Kin Group Pty Ltd, Microequities Asset Management Pty Limited, Lennox Capital Partners and others for approximately AUD 210 million.

McPherson's Limited Provides Earnings Guidance for the Full Year 2021

McPherson's Limited Not Providing Earnings Guidance Due to COVID-19

McPherson's Limited Appoints Ari Mervis as Independent, Non-Executive Director to the Board

Did You Participate In Any Of McPherson's' (ASX:MCP) Fantastic 149% Return ?

McPherson's Limited to Report First Half, 2021 Results on Feb 17, 2021

Are McPherson's's (ASX:MCP) Statutory Earnings A Good Guide To Its Underlying Profitability?

Declining Stock and Decent Financials: Is The Market Wrong About McPherson's Limited (ASX:MCP)?

A Look At The Intrinsic Value Of McPherson's Limited (ASX:MCP)

Investor sentiment improved over the past week

McPherson's CEO Change

Market pulls back on stock over the past week

New 90-day low: AU$1.15

Analysts Just Shaved Their McPherson's Limited (ASX:MCP) Forecasts Dramatically

Price target lowered to AU$2.36

Analysts lower EPS estimates to AU$0.083

Market pulls back on stock over the past week

Tread With Caution Around McPherson's Limited's (ASX:MCP) 5.0% Dividend Yield

New 90-day low: AU$2.18

Analysts update estimates

McPherson's Limited (ASX:MCP) entered into an agreement to acquire Global Therapeutics Pty Ltd from Blackmores Limited (ASX:BKL) for an enterprise value of AUD 27 million.

Analysts update estimates

New 90-day low: AU$2.64